Ownership history in XTX Topco Ltd · 7 quarters on record
This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in HALOZYME THERAPEUTICS INC (HALO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 21,340 | -8,568 | -28.6% | 0.08% | $1.6M | $73.34 |
| 2025 Q2 | ADDED | 29,908 | +11,538 | +62.8% | 0.06% | $1.6M | $52.02 |
| 2025 Q1 | ADDED | 18,370 | +3,911 | +27.0% | 0.06% | $1.2M | $63.81 |
| 2024 Q4 | REDUCED | 14,459 | -14,045 | -49.3% | 0.06% | $691K | $47.81 |
| 2023 Q3 | ADDED | 28,504 | +21,950 | +334.9% | 0.19% | $1.1M | $38.20 |
| 2023 Q2 | REDUCED | 6,554 | -7,320 | -52.8% | 0.04% | $236K | $36.07 |
| 2021 Q1 | INITIATED | 13,874 | — | — | 0.28% | $578K | $41.69 |
As of 2025 Q4 — sorted by position size